2026-2030年全球臨床質譜試劑市場

預計從 2025 年到 2030 年，全球臨床質譜試劑市場規模將成長至 7.972 億美元，預測期內複合年成長率為 8.9%。

本報告對全球臨床質譜試劑市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動此市場成長的因素包括：高通量液相層析質譜聯用技術在常規臨床診斷中的應用日益廣泛，其在治療藥物監測和臨床毒理學領域的應用不斷擴展，以及對新生兒篩檢和先天性代謝疾病分析的需求不斷成長。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，自動化質譜樣品製備的普及將是未來幾年全球臨床質譜試劑市場成長的主要驅動力之一。此外，質譜試劑在生物標記定量分析中的應用以及對高性能穩定同位素標記內標的需求激增，預計也將顯著推動市場需求的成長。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球臨床質譜試劑市場
• 產品類型細分市場分析，2020-2024 年
• 2020年至2024年最終用戶細分市場分析
• 2020-2024年基於技術的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球臨床質譜試劑市場
• 地緣政治衝突的影響：全球臨床質譜試劑市場

第7章：五力分析

第8章 市場區隔：依產品類型

• 比較：依產品類型
• 完整檢測試劑盒
• 內部標準
• 校準標準物質
• 品管材料
• 其他
• 市場機會：依產品類型分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院檢查室
• 獨立臨床實驗室
• 診斷中心
• 專業檢測實驗室
• 公共衛生檢測實驗室
• 市場機會：依最終用戶分類

第10章 市場區隔：依技術分類

• 比較：按技術
• LC-MS
• GC-MS
• MALDI-TOF MS
• ICP-MS
• 市場機會：依技術分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 荷蘭
  • 西班牙
  • 俄羅斯
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 新加坡
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 澳洲
  • 南非
  • UAE
  • 土耳其
  • 沙烏地阿拉伯
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Agilent Technologies Inc.
• Bio Rad Laboratories Inc.
• Biocrates Life Sciences AG
• BioMerieux SA
• Bruker Corp.
• Cambridge Isotope Laboratories
• Cayman Chemical Co.
• Danaher Corp.
• F. Hoffmann La Roche Ltd.
• Recipe Chemicals and Instruments
• Revvity Inc.
• Shimadzu Corp.
• Sigma Aldrich Chemicals Ltd.
• Thermo Fisher Scientific Inc.
• Waters Corp.

第16章附錄

The global clinical mass spectrometry reagents market is forecasted to grow by USD 797.2 mn during 2025-2030, accelerating at a CAGR of 8.9% during the forecast period. The report on the global clinical mass spectrometry reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of high-throughput lc-ms in routine clinical diagnostics, expanding applications in therapeutic drug monitoring and clinical toxicology, growing demand for neonatal screening and inborn errors of metabolism profiling.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global clinical mass spectrometry reagents market is segmented as below:

By Product Type

• Complete assay kits
• Internal standards
• Calibration standards
• Quality control materials
• Others

By End-User

• Hospital labs
• Independent clinical labs
• Diagnostic centers
• Specialty testing labs
• Public health labs

By Technology

• LC-MS
• GC-MS
• MALDI-TOF MS
• ICP-MS

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift toward automated mass spectrometry sample preparation as one of the prime reasons driving the global clinical mass spectrometry reagents market growth during the next few years. Also, integration of mass spectrometry reagents in biomarker quantification and surge in demand for ultra-high performance stable isotope labeled internal standards will lead to sizable demand in the market.

The report on the global clinical mass spectrometry reagents market covers the following areas:

• Global clinical mass spectrometry reagents market sizing
• Global clinical mass spectrometry reagents market forecast
• Global clinical mass spectrometry reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global clinical mass spectrometry reagents market vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Biocrates Life Sciences AG, BioMerieux SA, Bruker Corp., Cambridge Isotope Laboratories, Cayman Chemical Co., Danaher Corp., Eureka S.r.l., F. Hoffmann La Roche Ltd., Promega Corp., Randox Laboratories Ltd., RayBiotech Life Inc., Recipe Chemicals and Instruments, Revvity Inc., Shimadzu Corp., Sigma Aldrich Chemicals Ltd., Thermo Fisher Scientific Inc., Waters Corp., Zivak Technologies. Also, the global clinical mass spectrometry reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Clinical Mass Spectrometry Reagents Market 2020 - 2024
  • Historic Market Size - Data Table on Global Clinical Mass Spectrometry Reagents Market 2020 - 2024 ($ million)
• 5.2 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Clinical Mass Spectrometry Reagents Market
• 6.2 Impact of Geopolitical Conflicts on Global Clinical Mass Spectrometry Reagents Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product Type

• 8.1 Market segments
• 8.2 Comparison by Product Type
• 8.3 Complete assay kits - Market size and forecast 2025-2030
• 8.4 Internal standards - Market size and forecast 2025-2030
• 8.5 Calibration standards - Market size and forecast 2025-2030
• 8.6 Quality control materials - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospital labs - Market size and forecast 2025-2030
• 9.4 Independent clinical labs - Market size and forecast 2025-2030
• 9.5 Diagnostic centers - Market size and forecast 2025-2030
• 9.6 Specialty testing labs - Market size and forecast 2025-2030
• 9.7 Public health labs - Market size and forecast 2025-2030
• 9.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 LC-MS - Market size and forecast 2025-2030
• 10.4 GC-MS - Market size and forecast 2025-2030
• 10.5 MALDI-TOF MS - Market size and forecast 2025-2030
• 10.6 ICP-MS - Market size and forecast 2025-2030
• 10.7 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Singapore - Market size and forecast 2025-2030
  • 12.5.7 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Australia - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.6.6 Saudi Arabia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising adoption of high-throughput LC-MS in routine clinical diagnostics
  • Expanding applications in therapeutic drug monitoring and clinical toxicology
  • Growing demand for neonatal screening and inborn errors of metabolism profiling
• 13.2 Market challenges
  • High capital investment and elevated cost of clinical-grade mass spectrometry reagents
  • Complex regulatory frameworks and assay standardization hurdles
  • Shortage of skilled laboratory personnel and method technical complexity
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward automated mass spectrometry sample preparation
  • Integration of mass spectrometry reagents in biomarker quantification
  • Surge in demand for ultra-high performance stable isotope labeled internal standards

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.6 Biocrates Life Sciences AG
  • Biocrates Life Sciences AG - Overview
  • Biocrates Life Sciences AG - Product / Service
  • Biocrates Life Sciences AG - Key offerings
  • SWOT
• 15.7 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 15.8 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
  • SWOT
• 15.9 Cambridge Isotope Laboratories
  • Cambridge Isotope Laboratories - Overview
  • Cambridge Isotope Laboratories - Product / Service
  • Cambridge Isotope Laboratories - Key offerings
  • SWOT
• 15.10 Cayman Chemical Co.
  • Cayman Chemical Co. - Overview
  • Cayman Chemical Co. - Product / Service
  • Cayman Chemical Co. - Key offerings
  • SWOT
• 15.11 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 15.12 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.13 Recipe Chemicals and Instruments
  • Recipe Chemicals and Instruments - Overview
  • Recipe Chemicals and Instruments - Product / Service
  • Recipe Chemicals and Instruments - Key offerings
  • SWOT
• 15.14 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.15 Shimadzu Corp.
  • Shimadzu Corp. - Overview
  • Shimadzu Corp. - Business segments
  • Shimadzu Corp. - Key offerings
  • Shimadzu Corp. - Segment focus
  • SWOT
• 15.16 Sigma Aldrich Chemicals Ltd.
  • Sigma Aldrich Chemicals Ltd. - Overview
  • Sigma Aldrich Chemicals Ltd. - Product / Service
  • Sigma Aldrich Chemicals Ltd. - Key offerings
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 Waters Corp.
  • Waters Corp. - Overview
  • Waters Corp. - Business segments
  • Waters Corp. - Key offerings
  • Waters Corp. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations